期刊文献+

HBx与肝细胞脂肪变性关系及可能机制的细胞学研究 被引量:6

Relationship and Possible Mechanism of Hepatitis B Virus X Protein Expression with Hepatic Steatosis
下载PDF
导出
摘要 从细胞水平探讨乙型肝炎病毒X蛋白(hepatitis B virus X protein,HBx)与肝细胞脂肪变性的关系,并探讨其可能分子机制。油红O染色及细胞内甘油三酯含量测定鉴定HepG2.2.15细胞和HepG2细胞的脂变程度;Western blotting检测HBx,肝X受体(liver X receptor alpha,LXRα)及脂肪酸合成酶(fatty acid synthase,FAS)蛋白的表达。结果显示,C2.2.15组细胞脂变程度较CG2组细胞重。O2.2.15组细胞在24,48及72h的脂变程度及TG含量均较同一时间段的OG2组增加;Western blotting结果显示,HepG2.2.15细胞内有HBx蛋白表达,而HepG2细胞则无此蛋白表达;C2.2.15组细胞LXRα及FAS蛋白表达强度较CG2组细胞高。HBx蛋白与肝细胞脂肪变性存在密切的关系,其机制可能与HBx/LXRα/FAS信号通路有关。 Hepatic steatosis occurs in roughly a quarter to a half of patients with chronic hepatitis B (CHB) or chronic hepatitis C (CHC). However, the specific functions of hepatitis B virus X protein (HBx) , which include potential mechanisms of the regulation of hepatic adipogenic and lipogenic genes, remain to be poorly understood. Here we explored the HBx might be involed in HBV-associated hepatic steatosis via interacting with LXRα and FAS. Lipid accumulation in HepG2.2. 15 and HepG2 cells was observed by oil red O staining and TG content detection. HBx, LXRc( and FAS protein expression levels were measured by western blotting. Results showed that compared with the HepG2 cells, lipid droplets and the TG content were markedly increased in HepG2.2.15cells. The HBx was only existed in HepG2.2. 15 cells. The expression of LXRα and FAS proteins in HepG2. 2. 15 cells was obviously higher than that of HepG2 cells. Our results demonstrated that HBx interacts with LXRα, thereby resulting in the up-regulation of FAS which could be a putative molecular mechanism of HBV-associated hepatic lipid accumulation.
作者 郑黎黎 沈薇
出处 《生物技术通报》 CAS CSCD 北大核心 2010年第7期185-190,共6页 Biotechnology Bulletin
基金 国家自然科学基金(30871160)
关键词 乙型肝炎病毒X蛋白 HBV 肝细胞脂肪变性 Hepatitis B virus X protein Hepatitis B virus Hepatic steatosis
  • 相关文献

参考文献1

二级参考文献18

  • 1Teli MR,James OF,Burt AD.The natural history of nonalcoholic fatty liver disease.Hepatology 1994;22:1714-1719.
  • 2Caldwell S,Oelsner D,Iezzoni J,Hespenheide E,Battle E,Driscoll C. Cryptogenic cirrhosis:clinical characterization and risk factors for underlying disease.Hepatology 1999;29:664-669.
  • 3George D,Goldwurm S,MacDonald G,Cowley LL,Walker NI,Ward PJ, Jazwinska EC,Powell LW.Increased hepaticir on concentration in nonalcoholic steatohepatitis is associated with incresad fihrcosis. Gstroenterology 1998,114:311-318.
  • 4Schiff ER,Sorell MF,Maddrey WC.Disease of the Liver.6 th ed. Philedelphia:Lippincot- Williams and Wilkins,1999:1185-1197.
  • 5Adinolfi LE,Gambardella M,Andreana A,Tripodi MF,Utili R,Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.Hepatology 2001;33:1358-1364.
  • 6Hourigan LF,Macdonald GA,Purdie D,Whitehall VH,Shorthouse C, Clouston A,Powell EE.Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis.Hepatology 1999; 29:1215-1219.
  • 7Westin J,Nordlinger H,Lagging M,Norkans G,Wejstal R.Steatosis accelaerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.J Hepatol 2002;37:837-842.
  • 8Castera L,Hezode C,Roudot-Thoraval F,Bastie A,Zafrani ES,Patlowsky JM,Dhumeaux D.Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.Gut 2003;52:288-292.
  • 9Phillips MJ,Cameron R,Flowers MA,Blendis LM,Greig PD,Wanless I, Sherman M,Superina R,Langer B,Levy GA.Posttransplant recurrent hepatitis B viral liver disease.Viral-burden,steatoviral,and fibroviral hepatitis B.Am J Pathol 1992;140:1295-1308.
  • 10Matsumaru K,Ishii K,Shinora M,Sumino Y,Aikawa A,Hasegava A,Nonaka H, Akima M.A renal allograft recipientwith viral-burden,steatoviral, and fibroviral hepatitis B who achieved remission with lamuvidine.J Clin Gastroenterol 2003;36:187-188.

共引文献51

同被引文献52

  • 1Fu, Miao-Miao,Sun, Rui,Tian, Zhi-Gang,Wei, Hai-Ming.Increased susceptibility to experimental steatohepatitis induced by methionine-choline deficiency in HBs-Tg mice[J].Hepatobiliary & Pancreatic Diseases International,2010,9(5):513-519. 被引量:3
  • 2宋发军,黄珍,罗忠,张鹏,林爱华,孙东立,孟艳艳.代谢组学及其在药用植物研究中的应用[J].中南民族大学学报(自然科学版),2016,35(2):36-41. 被引量:8
  • 3杨林辉,陈东风.油酸诱导培养肝细胞脂肪变性模型的建立[J].重庆医学,2007,36(8):698-700. 被引量:29
  • 4Asselah T, Rubbia-Brandt L, Marcellin P, et al. Steatosis in chronic hepatitis C: why does it really matter? Gut, 2006, 55: 123-130.
  • 5Jhaveri R, McHutchison J, Patel K, et al. Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation. J Infect Dis, 2008, 197: 283-291.
  • 6Moriishi K, Mochizuki R, Moriya K, et al. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci U S A, 2007, 104: 1661- 1666.
  • 7Petta S, Camma C, Di Marco V, et al. Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Liver Int, 2011, 31 : 507- 515.
  • 8Tsochatzis E, Papatheodoridis GV, Manesis EK, et al. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C. Dig Liver Dis, 2007, 39: 936-942.
  • 9Gordon A, McLean CA, Pedersen JS, et al. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol, 2005, 43: 38-44.
  • 10Tang H, Oishi N, Kaneko S, et al. Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci, 2006, 97: 977-983.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部